Abbott Rapid Diagnostics A/S: Financial statements 2022
CVR: 24204650
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Abbott Rapid Diagnostics A/S (CVR 24204650) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 10,273,041 and a net result of DKK 697,158 compared with DKK 809,532 the year before. That is an increase of 3.2% compared with the year before. Equity in the 2022 report amounted to DKK 29,585,202. The solvency ratio was 86.4%. The company had 12 employees in the financial year.
- Gross Profit
- DKK 10,273,041
- Profit/Loss
- DKK 697,158
- Equity
- DKK 29,585,202
- Total Assets
- DKK 34,252,338
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 10.3 mio. | 697 t. | 29.6 mio. | 12 |
| 2021 | - | 10 mio. | 810 t. | 28.9 mio. | 12 |
| 2020 | - | 10 mio. | 647 t. | 28.1 mio. | 12 |
| 2019 | - | 15.3 mio. | 2.8 mio. | 27.4 mio. | 17 |
| 2018 | - | 14.9 mio. | 983 t. | 24.6 mio. | 19 |
Official annual report
Keep an eye on Abbott Rapid Diagnostics A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Abbott Rapid Diagnostics A/S has published its annual report for 2021. Gross profit came to DKK 9,954,905, and the net result was DKK 809,532.
About Abbott Rapid Diagnostics A/S
Abbott Rapid Diagnostics A/S is a Danish company of the type Aktieselskab based in København S, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ALERE A/S and MEDINOR A/S. The management consists of Berit Landsend-Holo. The board consists of Fredrik Björn Anders Björnulfson (chair), Berit Landsend-Holo and Mark Andrew Koewler. The company is owned by St. Jude Medical International Holding. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 2,286,557 and a net result of DKK 561,997 compared with DKK 854,423 the year before. Equity in the 2025 report amounted to DKK 32,222,511.